DOCTORAL NETWORK PLASMA MEDICINE AGAINST ACTINIC KERATOSIS
New cases per year are estimated in germany
0
Every second European citizen has developed an actinic keratosis by age 60
0
Up to 25% of European adults are believed to have at least one actinic keratosis
0
About PlasmACT
What is PlasmACT?
PlasmACT is a Marie Skłodowska-Curie Doctoral Network coordinated by the Leibniz Institute for Plasma Research and Technology in Greifswald, Germany, in collaboration with four other academic partners: University Medical Center Rostock, Germany, Eindhoven University of Technology, The Netherlands, Centre national de la recherche scientifique, France and University of Antwerp, Belgium.
In addition to our partners, our project also includes eight associated industry partners and two NGOs.
Our mission is to explore the potential of medical gas plasma technology in treating Actinic Keratosis, a common skin condition that can lead to skin cancer.